Related references
Note: Only part of the references are listed.Thermal Ablation Versus Stereotactic Body Radiotherapy After Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis
Nima Nabavizadeh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2021)
Post-treatment CT LI-RADS categories: predictors of overall survival in hepatocellular carcinoma post bland transarterial embolization
William E. L. Ormiston et al.
ABDOMINAL RADIOLOGY (2021)
Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017
Nieun Seo et al.
EUROPEAN RADIOLOGY (2020)
The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma
Mohammad Chaudhry et al.
RADIOLOGY (2020)
Stereotactic Body Radiation Therapy vs. Transarterial Chemoembolization in Inoperable Barcelona Clinic Liver Cancer Stage a Hepatocellular Carcinoma: A Retrospective, Propensity-Matched Analysis
Ting-Shi Su et al.
FRONTIERS IN ONCOLOGY (2020)
Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion
Ashwathy Susan Mathew et al.
EUROPEAN JOURNAL OF CANCER (2020)
Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions
Anum Aslam et al.
WORLD JOURNAL OF HEPATOLOGY (2020)
MRI Assessment of Hepatocellular Carcinoma after LocalRegional Therapy: A Comprehensive Review
Mishal Mendiratta-Lala et al.
RADIOLOGY-IMAGING CANCER (2020)
Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up
Mishal Mendiratta-Lala et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy
Erin L. Shropshire et al.
RADIOLOGY (2019)
A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy
W. C. Jackson et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis
Laura Kulik et al.
HEPATOLOGY (2018)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
An Tang et al.
ABDOMINAL RADIOLOGY (2018)
Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm
Ania Kielar et al.
ABDOMINAL RADIOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Krithika Suresh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma
Eli Sapir et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Role of Stereotactic Body Radiation Therapy Before Orthotopic Liver Transplantation: Retrospective Evaluation of Pathologic Response and Outcomes
Edward Michael Mannina et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
NCCN Guidelines® Insights Hepatobiliary Cancers, Version 1.2017 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
Assaf Moore et al.
RADIATION ONCOLOGY (2017)
Advances in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Louise J. Murray et al.
SEMINARS IN RADIATION ONCOLOGY (2017)
Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma
Guillaume Oldrini et al.
PLOS ONE (2017)
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
Daniel R. Wahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review
Nicola de'Angelis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The role of interventional radiology in the management of hepatocellular carcinoma
N. Molla et al.
CURRENT ONCOLOGY (2014)
Tumor Response on CT Following Hypofractionated Stereotactic Ablative Body Radiotherapy for Small Hypervascular Hepatocellular Carcinoma With Cirrhosis
Naoko Sanuki et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate
Matteo Cescon et al.
JOURNAL OF HEPATOLOGY (2013)
New OPTN/UNOS Policy for Liver Transplant Allocation: Standardization of Liver Imaging, Diagnosis, Classification, and Reporting of Hepatocellular Carcinoma
Christoph Wald et al.
RADIOLOGY (2013)
Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma
Tracy R. Price et al.
CANCER (2012)
Stereotactic Hypofractionated Radiation Therapy as a Bridge to Transplantation for Hepatocellular Carcinoma: Clinical Outcome and Pathologic Correlation
Alan W. Katz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
The Effectiveness of Locoregional Therapies versus Supportive Care in Maintaining Survival within the Milan Criteria in Patients with Hepatocellular Carcinoma
Renumathy Dhanasekaran et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
